You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALKS 33

Showing 1 - 25 of 928
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Bulgaria, Czechia, United States (Samidorphan (Low Dose), Samidorphan (Medium Dose), Samidorphan (High

Completed
Has Results
  • Schizophrenia
  • Samidorphan (Low Dose)
  • +4 more
  • Little Rock, Arkansas
  • +60 more
Sep 10, 2021

Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +

Completed
Has Results
  • Schizophrenia
  • Alcohol Use Disorder
  • Samidorphan + olanzapine (ALKS 3831)
  • Placebo + olanzapine
  • Little Rock, Arkansas
  • +70 more
Sep 14, 2021

MDD Trial in Australia, Puerto Rico, United States (ALKS 5461, ALKS 5461 Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • ALKS 5461 Placebo
  • Tucson, Arizona
  • +34 more
Mar 15, 2021

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, ALKS 4230 + pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • ALKS 4230 + pembrolizumab
  • Denver, Colorado
  • +30 more
Nov 23, 2022

Non-cutaneous Squamous Cell Carcinoma of Head and Neck Trial in United States (ALKS 4230, Pembrolizumab)

Completed
  • Non-cutaneous Squamous Cell Carcinoma of Head and Neck
  • Miami, Florida
  • +5 more
Nov 10, 2022

CNS Diseases Trial in Brisbane (Placebo, ALKS 1140)

Suspended
  • Central Nervous System Diseases
  • Placebo
  • ALKS 1140
  • Brisbane, Australia
    Alkermes Clinical Investigative Site
Feb 16, 2022

Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

Recruiting
  • Prostate Cancer
  • Nanjing, Jiangsu, China
    68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023

Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)

Active, not recruiting
  • Schizophrenia
  • +2 more
  • ALKS 3831
  • Little Rock, Arkansas
  • +85 more
Feb 10, 2022

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • Pembrolizumab
  • Los Angeles, California
  • +48 more
Feb 1, 2022

Hiv, Vaccine Reaction, Microbial Colonization Trial (B. infantis Rosell®-33, Placebo)

Not yet recruiting
  • Hiv
  • +3 more
  • B. infantis Rosell®-33
  • Placebo
  • (no location specified)
Jun 19, 2023

Healthy Females Trial (MsChief Classic Natural Lubricant, MsChief Ylang Ylang Natural Lubricant, MsChief Vanilla & Citrus

Not yet recruiting
  • Healthy Females
  • MsChief Classic Natural Lubricant
  • +3 more
  • (no location specified)
Feb 25, 2023

Robotic Versus Laparoscopic Roux En-y Gastric Bypass

Completed
  • Roux-en-y Anastomosis Site
  • +4 more
  • Roux en-Y gastric bypass
  • Foggia, Italy
    University of Foggia
Feb 23, 2023

Schizophrenia, Schizophreniform Disorders, Bipolar I Disorder Trial in Worldwide (ALKS 3831, Olanzapine)

Completed
  • Schizophrenia
  • +2 more
  • Little Rock, Arkansas
  • +56 more
Jan 5, 2022

VTE in 5774 Thoracic Trauma From 33 Hospitals in China, and

Completed
  • Thorax Injuries
  • +3 more
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University Affiliated Sixth People's Hospital
    Mar 4, 2023

    Diabetes, Type 2 Trial in Rawalpindi (Soleus Pushup Exercise, treadmill walk group 2)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Soleus Pushup Exercise
    • treadmill walk group 2
    • Rawalpindi, Punjab, Pakistan
      Railway General Hospital
    Sep 5, 2023

    Seborrheic Dermatitis, Papulopustular Rosacea Trial in New York (PF-07038124, Placebo Ointment)

    Recruiting
    • Seborrheic Dermatitis
    • Papulopustular Rosacea
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 22, 2023

    Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

    Completed
    • Human Papilloma Virus Infection
    • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
    • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
    • Nanjing, Jiangsu, China
      CDC, Jiangsu Province
    Jan 12, 2023

    Ankylosing Spondylitis, Aerobic Exercise, Disease Activity Trial in Afyonkarahisar (Aerobic exercises with cycling ergometry,

    Recruiting
    • Ankylosing Spondylitis
    • +2 more
    • Aerobic exercises with cycling ergometry
    • Stretching exercises
    • Afyonkarahisar, Turkey
      Afyonkarahisar Health Sciences University
    Jul 27, 2023

    Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

    Completed
    • Human Papillomavirus Infection
    • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
    • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
    • Nanjing, Jiangsu, China
      CDC, Jiangsu Province
    Jan 12, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Hangzhou, Zhejiang, China
      Department of Medical Onocology, First Affiliated Hospital of Zh
    Oct 7, 2023

    Thyroid Eye Disease Trial in Shanghai (IBI311, )

    Recruiting
    • Thyroid Eye Disease
    • IBI311
    • placebo
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
    Mar 20, 2023

    Incidence of Hemidiaphragmatic Palsy After Interscalene Block

    Suspended
    • Phrenic Nerve Paralysis
      • London, Ontario, Canada
        St. Joseph's Health Care
      Sep 23, 2022

      Type 2 Diabetes Trial in United States (Insulin glargine/Lixisenatide, Insulin glargine (HOE901), Background therapy)

      Terminated
      Has Results
      • Type 2 Diabetes Mellitus
      • Insulin glargine/Lixisenatide
      • +2 more
      • Montgomery, Alabama
      • +84 more
      Mar 21, 2022

      Preterm Premature Rupture of Membrane Trial in Paris (Nifedipine, Placebo of Nifedipine)

      Recruiting
      • Preterm Premature Rupture of Membrane
      • Paris, France
        Trousseau University Hospital
      Sep 20, 2022

      Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

      Not yet recruiting
      • Relapsed Acute Myeloid Leukaemia
      • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
      • (no location specified)
      Jul 4, 2023